SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Related Keywords

Ghana ,United States ,White House ,District Of Columbia ,Hawaii ,Tanzania ,Sudan ,Uganda ,Equatorial Guinea ,Mexico ,Hawaiians ,American ,Los Cabos ,Axel Lehrer ,Soligenix Inc ,Linkedin ,Centers For Disease ,Vaccine Technology ,Exchange Commission ,Twitter ,Johna Burns School Medicine ,Us Congress ,Our Public Health Solutions ,Vaccine Technology Ix Conference ,Company Public Health Solutions ,Vaccine Technology Conference ,National Institute Of Allergy ,Johna Burns School Of Medicine ,Nasdaq ,Defense Threat Reduction Agency ,Drug Administration ,Biomedical Advanced Research ,Development Authority ,University Of Hawai ,Professor Axel Lehrer ,Sudan Ebola ,Marburg Virus Vaccine ,Public Health Solutions ,Generally Recognized ,Orphan Drug Designation ,Advancing Vaccine Technologies ,Generally Regarded ,United States Food ,Biologics License Application ,Filovirus Infection ,Virus Disease ,Marburg Virus Disease ,Disease Control ,Ebola Virus Disease ,Sudan Virus ,Pandemic Preparedness ,Transforming Our ,School Medicine ,National Institute ,Infectious Diseases ,Project Bioshield ,Priority Review Voucher ,